Verschraegen, C.F.; Movva, S.; Ji, Y.; Schmit, B.; Quinn, R.H.; Liem, B.; Bocklage, T.; Shaheen, M.
A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma. Cancers 2013, 5, 418-429.
https://doi.org/10.3390/cancers5020418
AMA Style
Verschraegen CF, Movva S, Ji Y, Schmit B, Quinn RH, Liem B, Bocklage T, Shaheen M.
A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma. Cancers. 2013; 5(2):418-429.
https://doi.org/10.3390/cancers5020418
Chicago/Turabian Style
Verschraegen, Claire F., Sujana Movva, Yongli Ji, Berndt Schmit, Robert H. Quinn, Ben Liem, Therese Bocklage, and Monte Shaheen.
2013. "A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma" Cancers 5, no. 2: 418-429.
https://doi.org/10.3390/cancers5020418
APA Style
Verschraegen, C. F., Movva, S., Ji, Y., Schmit, B., Quinn, R. H., Liem, B., Bocklage, T., & Shaheen, M.
(2013). A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma. Cancers, 5(2), 418-429.
https://doi.org/10.3390/cancers5020418